HSKA News Alert Heska Corp (HSKA) 20.95 02/14/2015 08:29:00

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Heska Corp (HSKA) 20.95 $HSKA

Nasdaq stocks posting largest percentage decreases
AP - Thu Feb 12, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
PNTR: 7.90 (+0.01), INO: 6.80 (-0.15), HSKA: 20.95 (+0.07), JIVE: 5.34 (+0.02), CAKE: 48.22 (-1.04), CERU: 6.62 (-0.06), MKTO: 28.24 (+0.20), ANDE: 45.11 (+0.71), ZU: 14.22 (-0.30)

Heska Corporation (HSKA) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 8:32AM CST
Heska Corporation (HSKA) was a big mover last session, as the company saw its shares rise more than 7% on the day.
HSKA: 20.95 (+0.07), OPHT: 51.11 (+0.12)

Heska (HSKA) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 02, 7:00AM CST
Heska (HSKA) Shares March Higher, Can It Continue?
HSKA: 20.95 (+0.07)

Heska Signs Distribution Agreement with scil animal care company
PR Newswire - Thu Jan 29, 8:00AM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company" , a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today a new distribution agreement with the Canadian unit ("scil animal care company Canada" of scil animal care company, a companion animal health distribution company serving Canada, the United States and Europe. scil animal care company Canada will market and promote Heska's full line of hematology, blood gas & electrolytes and chemistry instruments and affiliated consumables, effective immediately.
HSKA: 20.95 (+0.07)

Bonnie Trowbridge, CPA, Joins Heska's Board of Directors
PR Newswire - Wed Jan 28, 8:00AM CST
Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company" , a leading provider of veterinary diagnostic and specialty products, announced today that Bonnie J. Trowbridge, CPA, has joined Heska's Board of Directors, adding a wealth of financial expertise to the board.
HSKA: 20.95 (+0.07)

Announcing This Week's Outstanding Performance Award Winners - BuyTheDip SellTheRip And Illuminati Investments
SA Editor Daniel Shvartsman - Seeking Alpha - Mon Jan 05, 4:00AM CST
Dear readers, We're kicking off 2015 with a couple ideas that played out fantastically in 2014 and are worthy Outstanding Performance award winners. One was a long idea from 2013 that called for a double in 2014, a move that indeed played out....
HSKA: 20.95 (+0.07), CONN: 24.69 (-0.07)

Heska to Present at Sidoti Emerging Growth Institutional Investor Forum
PR Newswire - Tue Dec 30, 3:01PM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company" , a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today Dr. Robert Grieve, Executive Chair, will present at The Sidoti Company, LLC's 2015 Emerging Growth Institutional Investor Forum on Monday, January 12, 2015. The company's group presentation is scheduled for 8 a.m. (ET) in Estate 3 and management will be available throughout the day for one-on-one meetings. Please email hska@haydenir.com or contact your Sidoti representative to schedule a one-on-one meeting.
HSKA: 20.95 (+0.07)

Can The Uptrend Continue for Heska (HSKA)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 8:49AM CST
Can The Uptrend Continue for Heska (HSKA)?
HSKA: 20.95 (+0.07)

One Stock Chart Trick You Should All Know - Investment Ideas
David Bartosiak - ZACKS - Tue Dec 16, 12:00AM CST
One Stock Chart Trick You Should All Know - Investment Ideas
HSKA: 20.95 (+0.07), ANIP: 62.69 (-0.43), SCMP: 15.32 (+0.04)

Heska to Attend Benchmark Micro Cap Discovery Conference
PR Newswire - Tue Nov 25, 3:01PM CST
Heska Corporation (NASDAQ: HSKA) - (News; "Heska" or the "Company" , a provider of advanced veterinary diagnostic and other specialty veterinary products, announced today Dr. Robert Grieve, Executive Chair, will attend The Benchmark Company, LLC's Micro Cap Discovery Conference on Thursday, December 11, 2014. The one-on-one conference will be held at The Palmer House Hilton, 17 E. Monroe Street, Chicago, IL from 8 a.m. to 2:30 p.m. Please email hska@haydenir.com or contact your Benchmark representative to schedule a one-on-one meeting.
HSKA: 20.95 (+0.07)

Why Intercept Pharmaceuticals (ICPT) Could Be Positioned for a Slump - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 25, 7:40AM CST
Intercept Pharmaceuticals has witnessed a significant price decline in the past four weeks and negative earnings estimate revisions for the current quarter and the current year, making it time for investors to sell it off
HSKA: 20.95 (+0.07), ICPT: 209.12 (+7.12), AMAG: 41.49 (+0.23), DYAX: 15.00 (-0.16)

Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 21, 4:20PM CST
On Nov 21, Zacks Investment Research upgraded Illumina Inc. (ILMN) to a Zacks Rank #1 (Strong Buy).
BIIB: 391.66 (-0.45), HSKA: 20.95 (+0.07), ILMN: 198.54 (+1.81), AFFX: 11.45 (+0.02)

Heska analyst day leaves Feltl bullish
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 2:45PM CST

HSKA: 20.95 (+0.07), ABAX: 60.93 (+0.65), IDXX: 159.08 (+1.72)

Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 20.95 (+0.07), ACHN: 10.89 (-0.20), ILMN: 198.54 (+1.81), AFFX: 11.45 (+0.02)

Achillion Pharmaceuticals Slumps: ACHN Plunges 15.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 7:34AM CST
Achillion Pharmaceuticals (ACHN) fell nearly 16% in the last trading session amid huge volumes, reversing its recent trend, as the stock is now up nearly 3% in the past one month.
AGEN: 5.03 (-0.01), HSKA: 20.95 (+0.07), ACHN: 10.89 (-0.20), AMAG: 41.49 (+0.23)

Heska Announces Investor Day in New York City
PR Newswire - Tue Nov 04, 8:00AM CST
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company" , a provider of advanced veterinary diagnostic and other specialty veterinary products, today announced the Company will conduct an Investor Day, from 9 a.m. to noon (EST) on Friday, November 14, 2014. The event will be at the Nasdaq MarketSite in Times Square, located at One Liberty Plaza, 165 Broadway, in New York City.
HSKA: 20.95 (+0.07)

Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:50PM CDT
Qiagen's (QGEN) strategic collaborations, test menu expansions and moderately balanced international expansion will likely drive growth over time.
BIIB: 391.66 (-0.45), HSKA: 20.95 (+0.07), ILMN: 198.54 (+1.81), QGEN: 23.68 (-0.06)

Can the Rally in Heska (HSKA) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:06AM CDT
Can the Rally in Heska (HSKA) Shares Continue?
HSKA: 20.95 (+0.07)

Heska's (HSKA) CEO Kevin Wilson on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 29, 7:40PM CDT

HSKA: 20.95 (+0.07)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Next Bridge's Unresolved SEC Showdown Continues

Updated Category News Views 17

Frustration Thickens in Next Bridge's SEC Stand-Off Okay, so here we go again. Next Bridge Hydrocarbons is banging on the SEC's door for the sixth time and getting the same old silent treatment. If you're keeping track, this is about the unresolved MMTLP trading halt from 2022 that's thrown a wrench in their shareholder ledger. It's like asking the waiter for your check...

Continue Reading
HUMAIN's $3 Billion xAI Bet: A Bold Move or a Risky Play?

Updated Category News Views 171

HUMAIN dropped a staggering $3 billion into xAI's Series E financing round right before its acquisition by SpaceX, signaling a high-stakes gamble. As the dust settles from this monumental investment, questions linger over HUMAIN’s strategy and the implications for both entities in the AI landscape. HUMAIN’s Strategic Maneuver: Investment Insights This $3 billion...

Continue Reading
Exciting Insights From Avance Gas Holding Ltd's Upcoming Q4 Results

Updated Category News Views 207

Exciting Insights From Avance Gas Holding Ltd's Upcoming Q4 Results As we approach the end of the financial year, many companies are gearing up to share important information with their stakeholders. Avance Gas Holding Ltd, known by its ticker AGAS, is no exception. This renowned company is set to release its unaudited results for the fourth quarter of 2024 in early...

Continue Reading
Coca-Cola to Reveal Q3 2024 Results with Investor Call

Updated Category News Views 177

Coca-Cola Company’s Upcoming Q3 Earnings Release The Coca-Cola Company has revealed its plans to release third-quarter financial results for 2024 on a date that will be announced soon, prior to the market opening. This eagerly awaited report will be followed by an investor conference call that will offer insights on financial performance and future projections. Details...

Continue Reading
Manhattan Associates Recognized as a Leader in Retail Solutions

Updated Category News Views 200

Manhattan Associates Named Leader in Retail Solutions Manhattan Associates Inc. (NASDAQ: MANH) has recently achieved the prestigious title of Leader in the Forrester Wave report focused on Point-of-Service (POS) Solutions. This recognition shines a spotlight on the company's innovative approach within the ever-evolving landscape of retail technology. Innovations in...

Continue Reading